contract research, medical device development, or diagnostics, today announced its full-year ended December 31, 2024 financial results and provided clinical and corporate updates. We intend to be ...

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

Financial resources of CHF 145.7 million provide funding into Q1 2027, suggesting stability and the ability to advance multiple clinical trials and programs. Participation in the AD/PD™ 2025 ...

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...

Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX ...

Clinical academia is on a steep decline globally. In the UK, a 6% reduction in the number of clinical academics since 2012 has been reported, with the number of senior lecturer level researchers ...

Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM ...

2 Non-GAAP research and development expenses exclude ... consumer marketing activities and of certain other expenses. Other Financial Information Change in fair value of acquisition-related ...

The upcoming randomized, blinded, placebo-controlled clinical ... its solid financial position, with a cash runway extending into 2028, allowing it to continue operations and research without ...

The Education Department announced Friday it was requesting records from Harvard University over allegations of inaccurate foreign financial disclosures ... in our research and teaching mission ...

Research from Harvard Kennedy School’s Marcella Alsan shows Black survey respondents’ interest in clinical trials increased when a Black investigator was involved.

Operator: Good afternoon, and welcome to Huron Consulting Group’s webcast to discuss Financial Results for the First Quarter ...